CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 933000-933110
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T67169","span":{"begin":0,"end":110},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The antigenic targets of the intrathecal B cell response in patients with multiple sclerosis (MS) are unknown."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T2043","span":{"begin":0,"end":110},"obj":"Epistemic_statement"}],"text":"The antigenic targets of the intrathecal B cell response in patients with multiple sclerosis (MS) are unknown."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T311","span":{"begin":0,"end":110},"obj":"Sentence"}],"text":"The antigenic targets of the intrathecal B cell response in patients with multiple sclerosis (MS) are unknown."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3876","span":{"begin":94,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A3876","pred":"uberon_id","subj":"T3876","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"The antigenic targets of the intrathecal B cell response in patients with multiple sclerosis (MS) are unknown."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5849","span":{"begin":74,"end":92},"obj":"Disease"},{"id":"T5850","span":{"begin":94,"end":96},"obj":"Disease"},{"id":"T67358","span":{"begin":74,"end":92},"obj":"Disease"},{"id":"T10438","span":{"begin":94,"end":96},"obj":"Disease"}],"attributes":[{"id":"A5849","pred":"mondo_id","subj":"T5849","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A5850","pred":"mondo_id","subj":"T5850","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A33281","pred":"mondo_id","subj":"T67358","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A28896","pred":"mondo_id","subj":"T10438","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"The antigenic targets of the intrathecal B cell response in patients with multiple sclerosis (MS) are unknown."}